YD Bio Limited Ordinary Shares (YDES) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 192.08K | 233.63K | 3.47M | 193.06K | 311.3K | 238.21K | 266.14K |
| Cash & Short-Term Investments | 6.31K | 403 | 3.13M | 0 | 39.97K | 4.49K | 4.23K |
| Cash Only | 6.31K | 403 | 3.13M | 0 | 39.97K | 4.49K | 4.23K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 53.91K | 53.91K | 262.8K | 53.91K | 53.91K | 18.67K | 18.67K |
| Days Sales Outstanding | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 37.34K | 0 | 0 | 0 | 69.4K |
| Days Inventory Outstanding | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | -69.4K |
| Total Non-Current Assets | 2.76M | 3.28M | 3.4M | 10.58M | 10.38M | 13.27M | 12.98M |
| Property, Plant & Equipment | 0 | 0 | 88.08K | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 2.68M | 0 | 0 | 0 | 0 |
| Long-Term Investments | 2.76M | 3.28M | 10.53M | 10.58M | 10.38M | 13.27M | 12.98M |
| Other Non-Current Assets | 0 | 0 | -9.9M | 0 | 0 | 0 | 0 |
| Total Assets | 2.95M | 3.52M | 6.86M | 10.77M | 10.69M | 13.51M | 13.24M |
| Asset Turnover | - | - | - | - | - | - | - |
| Asset Growth % | -72.39% | -73.97% | -48.17% | - | - | - | - |
| Total Current Liabilities | 11.22M | 10.84M | 263.06K | 10.09M | 9.89M | 9.22M | 8.08M |
| Accounts Payable | 0 | 0 | 26.74K | 0 | 0 | 0 | 17.98K |
| Days Payables Outstanding | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 290 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 11.15M | 10.78M | 0 | 10.06M | 9.89M | 9.22M | 7.84M |
| Current Ratio | 0.02x | 0.02x | 13.18x | 0.02x | 0.03x | 0.03x | 0.03x |
| Quick Ratio | 0.02x | 0.02x | 13.04x | 0.02x | 0.03x | 0.03x | 0.02x |
| Cash Conversion Cycle | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.79M | 5.92M | 10.92K | 3.55M | 5.86M | 23.33M | 2.2M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 5.68K | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 1.46K | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 7.79M | 5.92M | 3.77K | 3.55M | 5.86M | 23.33M | 2.2M |
| Total Liabilities | 19M | 16.76M | 273.98K | 13.64M | 15.75M | 32.56M | 10.28M |
| Total Debt | 0 | 0 | 22.55K | 0 | 0 | 0 | 0 |
| Net Debt | -6.31K | -403 | -3.11M | 0 | -39.97K | -4.49K | -4.23K |
| Debt / Equity | - | - | 0.00x | - | - | - | - |
| Debt / EBITDA | - | - | 0.05x | - | - | - | - |
| Net Debt / EBITDA | - | - | -7.44x | - | -0.00x | - | -0.01x |
| Interest Coverage | - | - | - | - | - | - | - |
| Total Equity | -16.05M | -13.25M | 6.59M | -2.87M | -5.06M | -19.05M | 2.97M |
| Equity Growth % | -217.28% | 30.47% | 122.19% | - | - | - | - |
| Book Value per Share | -4.71 | -3.87 | 1.63 | -0.71 | -1.20 | -4.43 | 0.69 |
| Total Shareholders' Equity | -16.05M | -13.25M | 6.59M | -2.87M | -5.06M | -19.05M | 2.97M |
| Common Stock | 2.66M | 3.18M | 144.18K | 10.48M | 10.28M | 13.17M | 12.65M |
| Retained Earnings | -18.71M | -16.43M | -1.93M | -13.35M | -15.34M | -32.22M | -9.68M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 45.07K | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |